| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/09/1989 | EP0327389A2 Tumour imaging |
| 08/09/1989 | EP0327365A2 Improvements in or relating to modified haptens useful as imaging and therapeutic agents |
| 08/09/1989 | EP0326595A1 Peptides and antibodies that inhibit platelet adhesion |
| 08/02/1989 | EP0326381A2 Use of 6RF in the diagnosis of M. Alzheimer |
| 08/02/1989 | EP0326226A1 Paramagnetic compounds |
| 08/02/1989 | EP0325762A1 Macrocyclic chelating agents and chelates thereof |
| 08/02/1989 | EP0325639A1 Fibrin-binding compound and method |
| 07/27/1989 | WO1989006703A1 Diagnosis of retinoblastoma |
| 07/26/1989 | EP0325225A2 Concentrates of coagulation factors II, VII, IX and/or X, their preparation and use, and method for the determination of coagulation factor VII |
| 07/26/1989 | EP0324938A1 Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production |
| 07/25/1989 | US4851448 Gem-dihalo-1,8-diamino-4-aza-octanes |
| 07/25/1989 | US4851338 Method for diagnosing the presence of bacteria |
| 07/18/1989 | US4849406 Aprotinin |
| 07/18/1989 | US4849210 Magnetic resonance imaging of liver and spleen with superparamagnetic contrast agents |
| 07/18/1989 | US4848349 Substance and method for measuring hepatic blood flow |
| 07/18/1989 | CA1257601A1 Coupling agents for radiolabeled antibody fragments |
| 07/13/1989 | WO1989006242A1 Antibodies to a4 amyloid peptide |
| 07/13/1989 | DE3744518A1 Ferromagnetic antibodies for contrast enhancement of in vivo magnetic resonance imaging |
| 07/11/1989 | US4847049 Method of forming chelated collagen having bactericidal properties |
| 07/05/1989 | EP0322795A2 Novel tetrapyrrole aminocarboxylic acids |
| 07/04/1989 | US4845090 Nuclear magnetic resonance |
| 07/04/1989 | US4844905 Granule remaining in stomach |
| 07/04/1989 | US4844882 Concentrated stabilized microbubble-type ultrasonic imaging agent |
| 07/04/1989 | US4844096 Method of diagnosing growth hormone disorders employing somatostatin infusion |
| 06/29/1989 | WO1989005802A1 Macrocyclic chelating agents and chelates thereof |
| 06/29/1989 | WO1989005638A1 Emulsion for parenteral administration |
| 06/28/1989 | EP0322350A1 Use of media containing bubbles in shock wave and supersonic therapy |
| 06/26/1989 | EP0244444A4 Magnetic-polymer particles. |
| 06/21/1989 | EP0321429A1 Emulsion for parenteral administration |
| 06/21/1989 | EP0321322A1 Magnetic composite particles from crosslinked organopolysiloxane, process for their preparation and use of them in biology |
| 06/20/1989 | CA1256249A1 Diagnostic preparations and their use |
| 06/20/1989 | CA1256030A1 Composition for ophthalmological use |
| 06/15/1989 | WO1989005452A1 Measurement of pge2 (prostaglandin e2) levels in patients with chronic inflammatory bowel disease |
| 06/15/1989 | WO1989005160A1 Use of media containing bubbles in shock wave and ultrasonic therapy |
| 06/15/1989 | WO1989005159A1 Ultrasonic or shock wave operating process and agent for implementing said process |
| 06/15/1989 | WO1989005155A1 Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells |
| 06/14/1989 | EP0320433A2 Process using ultrasonic or shock waves, and means for carrying it out |
| 06/13/1989 | US4838274 Perfluoro-crown ethers in fluorine magnetic resonance imaging |
| 06/07/1989 | EP0318948A2 Cleavable immunoconjugates for the delivery and release of agents in native form |
| 06/06/1989 | US4837171 Anti-epiglycanin monoclonal antibodies |
| 06/06/1989 | US4836217 Hypersensitivity test means |
| 06/06/1989 | CA1255219A1 Non-radioactively labeled microspheres and use of same to measure blood flow |
| 06/06/1989 | CA1255211A2 Device and method for testing for immune responses to food |
| 05/30/1989 | US4834964 Use of charged nitroxides as NMR image enhancing agents for CSF |
| 05/24/1989 | EP0317492A2 Substituted dicarboxylic acids-bis(3,5-dicarbamoyl-2,4,6-triiodo-anilides), process for their preparation and X-ray contrast agents containing them |
| 05/23/1989 | US4832941 Cardiovascular disorders |
| 05/23/1989 | US4832940 Method of locating or imaging activated T-lymphocytes with a targeting polypeptide |
| 05/17/1989 | EP0315931A2 Fluorine-containing protoporphyrin derivatives and their salts |
| 05/17/1989 | EP0315670A1 Test patch for demonstrating contact allergy. |
| 05/10/1989 | EP0315220A1 Method of forming a metal chelate protein conjugate |
| 05/10/1989 | EP0314764A1 Injectable opacifying liposome composition. |
| 05/09/1989 | US4827945 Magnetic resonance imaging |
| 05/09/1989 | CA1253799A1 Nmr contrast agents |
| 05/05/1989 | WO1989003693A1 Method of using fluorocarbons in nuclear magnetic resonance imaging |
| 05/05/1989 | WO1989003675A1 Superparamagnetic particles, a way of producing said particles and their use |
| 05/05/1989 | WO1989003674A1 Microspheres, way of producing said microspheres and the use thereof |
| 05/03/1989 | EP0314239A2 Tripeptide renin inhibitors with N-terminal ureido or sulfamido groups |
| 05/03/1989 | EP0313942A1 Use of fluorane derivatives and contrast medium for cancerous growth diagnosis |
| 05/02/1989 | US4826689 Method for making uniformly sized particles from water-insoluble organic compounds |
| 05/02/1989 | US4826673 Methods and compositions for enhancing magnetic resonance imaging |
| 05/02/1989 | CA1253514A1 Complexing agents, complexes and complex salts |
| 04/26/1989 | EP0312543A1 $i(IN SITU) ACTIVE COMPOUND ASSEMBLY |
| 04/25/1989 | US4824986 Diethylenetriaminepentaacetic acid substituted with isothiocyanate or n-hydroxysuccinimide |
| 04/25/1989 | US4824659 Antibody conjugates |
| 04/19/1989 | EP0312291A2 Di-or tripeptide renin inhibitors containing lactam conformational restriction in ACHPA |
| 04/19/1989 | EP0312108A1 Contrast medium for cancerous growth diagnosis |
| 04/18/1989 | US4822594 Contrast enhancing agents for magnetic resonance images |
| 04/18/1989 | CA1252950A1 Magnetic particles for diagnostic purposes |
| 04/18/1989 | CA1252714A1 Diagnostic agent for heart disease and use thereof |
| 04/12/1989 | EP0310645A1 Compounds useful particularly for radiotherapy or imaging of cancer. |
| 04/11/1989 | US4820732 Method and compositions for reducing dysfunction in angioplasty procedures |
| 04/11/1989 | US4820632 Agent and process for the detection of redox systems |
| 04/11/1989 | US4820505 Detection of activated platelets with antibodies to thrombospondin |
| 04/05/1989 | CN1032107A Contact agent for probe of medical supersonic diagnosing instrument |
| 04/04/1989 | US4818707 Device and mixture for testing for immune responses to food |
| 04/04/1989 | US4818516 Method of nutritional assessment and therapy |
| 03/29/1989 | EP0308983A2 NMR imaging with Mn(II) coordination compositions |
| 03/23/1989 | WO1989001342A3 Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound |
| 03/22/1989 | EP0308364A2 Dicarboxylic acid-bis(3,5-dicarbamoyl-2-4-6-triiodanilides), process for their preparation and X-ray contrast agents containing them |
| 03/22/1989 | EP0307863A1 Perfluoro-crown ethers in fluorine magnetic resonance imaging |
| 03/14/1989 | US4811741 Volumetric determination of a fluid |
| 03/09/1989 | WO1989001758A1 Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment |
| 03/08/1989 | EP0306168A1 Preparation of radiolabeled conjugates |
| 03/08/1989 | EP0305497A1 Fertility prediction by use of clomiphene challenge test. |
| 03/07/1989 | US4810655 Quenching of luminescence |
| 03/07/1989 | US4810401 Superparamagnetic solid particles |
| 03/01/1989 | EP0305320A2 Multinucleic substituted complexants, complexes and complex salts, process for their preparation and pharmaceutical agents containing them |
| 02/28/1989 | US4808399 Composition for diagnosing the transport function of the fallopian tube and a method for preparing said composition |
| 02/23/1989 | WO1989001476A1 Tetra-aza macrocycles and metal complexes thereof |
| 02/23/1989 | WO1989001475A1 Tri-aza macrocycles and metal complexes thereof |
| 02/23/1989 | WO1989001343A1 Cationized antibodies for delivery through the blood-brain barrier |
| 02/23/1989 | WO1989001342A2 Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound |
| 02/22/1989 | EP0303692A1 Cloning of lfa-1 |
| 02/21/1989 | US4805623 Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment |
| 02/14/1989 | US4804529 Use of specific relaxation agents for organs or pathologies for modifying the contrasts in medical imaging by nuclear magnetic resonance |
| 02/09/1989 | WO1989000997A1 Ionophores as reagents for detecting ions |
| 02/09/1989 | WO1989000988A1 Iodinated esters |
| 02/01/1989 | EP0301759A2 Bone cement for controlled release of substances |
| 01/31/1989 | US4801535 Method for detection of periodontal disease |
| 01/26/1989 | WO1989000692A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |